Daniel Alfaiate | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Daniel Alfaiate
Instituto Politécnico de Castelo Branco, Portugal

Daniel Alfaiate
Affiliation Instituto Politécnico de Castelo Branco
Country Portugal
Scopus ID 58158006300
Documents 3
Citations 31
h-index 2
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-5581-4242

Daniel Alfaiate is a researcher affiliated with the Instituto Politécnico de Castelo Branco whose documented scholarly activity is situated within Medicine and Health Sciences. The available publication record includes research concerning sleep medicine, obstructive sleep apnea (OSA), electroencephalography, hematological outcomes, and psychotropic medication effects on sleep architecture. Bibliographic information identifies three Scopus documents and 31 citations, with a reported h-index of 2.

Abstract

The research profile of Daniel Alfaiate reflects an emerging focus on clinical and physiological dimensions of sleep and neurological assessment. His documented works address OSA, wakefulness electroencephalography, hematocrit and erythrocytosis, and the effects of psychotropic medication on sleep architecture. These subjects connect diagnostic assessment with clinically relevant sleep outcomes and provide a coherent basis for evaluating research activity in Medicine and Health Sciences. [1]

Keywords

Sleep medicine; obstructive sleep apnea; electroencephalography; polysomnography; sleep architecture; psychotropic medication; hematocrit; erythrocytosis; clinical research.

Introduction

Sleep disorders can involve respiratory, neurological, cardiovascular, and behavioral dimensions, making multidisciplinary clinical research particularly relevant. OSA is associated with measurable physiological changes and may require complementary diagnostic approaches. Research examining wakefulness EEG and hematological characteristics contributes to the broader clinical understanding of patients evaluated for sleep-related disorders. [2] [3]

Research Profile

The available record indicates a focused research trajectory around sleep-related clinical investigation. The profile combines observational clinical work with physiological measurement, including polysomnographic assessment and electroencephalographic evaluation. Bibliometric indicators reported for the researcher include three documents, 31 citations, and an h-index of 2. [1]

Research Contributions

The documented publications address complementary aspects of sleep-related medicine. One study examines the relationship between OSA and hematocrit or erythrocytosis, while another evaluates wakefulness EEG in OSA patients. A later article investigates class-specific and cumulative effects of psychotropic medication on sleep architecture using retrospective polysomnographic data. [2] [3] [4]

Publications

  • Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study. European Journal of Pharmacology, 2026. [4]
  • Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study. Sleep and Breathing, 2025. [2]
  • Evaluation of wakefulness electroencephalogram in OSA patients. Sleep and Breathing, 2024. [3]
  • Evaluation of wakefulness electroencephalogram in OSA patients. Research Square, 2024. [5]
  • O Eletroencefalograma Emergente nos Cuidados Intensivos. Repositório Científico do Instituto Politécnico de Castelo Branco, 2023. [6]

Research Impact

The reported bibliometric record of 31 citations and an h-index of 2 provides a measurable indication of scholarly visibility. The publications also demonstrate continuity in sleep-related research across 2023–2026, with topics spanning intensive care, OSA assessment, hematological outcomes, and medication-associated changes in sleep architecture. [1]

Award Suitability

For the Best Researcher Award category, the documented record provides evidence of peer-reviewed research activity in a defined medical research area. The combination of recent journal publications, sleep-medicine investigations, and identifiable bibliometric indicators offers an objective basis for consideration. Award assessment should additionally consider authorship roles, methodological quality, peer-review status, broader collaboration, and independent verification of bibliographic records.

Conclusion

Daniel Alfaiate’s documented research activity centers on clinically relevant questions in sleep and neurological assessment. His publications provide a coherent research profile involving OSA, EEG evaluation, hematological outcomes, and polysomnographic investigation. The available bibliometric and publication evidence supports consideration within an academic recognition framework, subject to standard verification procedures.

References

  1. Elsevier. (n.d.). Scopus author details: Daniel Alfaiate, Author ID 58158006300. Scopus.
    https://www.scopus.com/pages/authors/58158006300
  2. Springer Nature. (2025). Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study. Sleep and Breathing.
    DOI: 10.1007/s11325-025-03330-2
  3. Springer Nature. (2024). Evaluation of wakefulness electroencephalogram in OSA patients. Sleep and Breathing.
    DOI: 10.1007/s11325-024-03116-y
  4. Elsevier. (2026). Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study. European Journal of Pharmacology.
    DOI: 10.1016/j.ejphar.2026.179292
  5. Research Square. (2024). Evaluation of wakefulness electroencephalogram in OSA patients.
    DOI: 10.21203/rs.3.rs-3831506/v1
  6. Instituto Politécnico de Castelo Branco. (2023). O Eletroencefalograma Emergente nos Cuidados Intensivos. Repositório Científico do Instituto Politécnico de Castelo Branco.